Press Releases Novavax, Inc.

Equities

NVAX

US6700024010

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
15.5 ^USD	+2.31%		+7.64%	+222.92%

May. 24	Novavax awaits FDA decision on whether its next COVID shot can be offered in US	RE
May. 23	Novavax, Inc. Notifies Retirement of Filip Dubovsky as President, Research and Development, Effective as of June 30, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Serum Institute of India Ships Its First Set of R21/Matrix-M? Malaria Vaccine Doses to Africa [press release]	May. 20	AQ
Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting	May. 20	AQ
Novavax to Participate in BofA Securities 2024 Health Care Conference	May. 13	PR
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines	May. 13	AQ
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights	May. 13	AQ
Q1 2024 Earnings presentation	May. 10	PU
Novavax: Q1 Earnings Snapshot	May. 10	AQ
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights	May. 10	PR
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024	May. 07	PR
Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting	May. 06	AQ
Novavax : Prepared to Deliver Protein-based Non-mRNA JN.1 COVID-19 Vaccine in Line with WHO Recommendation this Fall	Apr. 26	PU
Novavax : to Supply Updated COVID-19 Vaccine to Private Healthcare Providers in the United Kingdom	Apr. 18	PU
Shah Capital nominates two highly qualified independent director candidates for Novavax	Apr. 15	AQ
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024	Apr. 01	PR
Novavax to Participate in TD Cowen's 44th Annual Health Care Conference	Feb. 29	PR
Novavax's Protein-based Non-mRNA COVID-19 Vaccine Available Now as Additional Dose for Individuals Aged 65 and Older Following U.S. CDC Advisory Committee Recommendation	Feb. 29	AQ
Novavax: Q4 Earnings Snapshot	Feb. 28	AQ
Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	Feb. 28	PR
Exploring Stocks with High Short Interest: INBS, BLNK, BYND, NVAX, PLUG	Feb. 28	AQ
Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement	Feb. 22	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Novavax Surges on $1.2 Billion Sanofi Vaccine Deal

May 10, 2024 at 02:52 pm EDT